A Randomized Comparison of a Biolimus-Eluting Stent With a Sirolimus-Eluting Stent for Percutaneous Coronary Intervention

Trial Profile

A Randomized Comparison of a Biolimus-Eluting Stent With a Sirolimus-Eluting Stent for Percutaneous Coronary Intervention

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Umirolimus (Primary) ; Sirolimus
  • Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Myocardial ischaemia
  • Focus Registrational; Therapeutic Use
  • Acronyms LEADERS
  • Sponsors Biosensors International Group
  • Most Recent Events

    • 21 May 2015 Results published in EuroPCR, as per Biosensors International Group media release.
    • 23 Oct 2012 Five-year results presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, according to a Biosensors International Group media release.
    • 27 Mar 2012 Pooled analysis presented at the 61st Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top